Over-the-counter nicotine replacement therapy for everyone: Is it the best solution?

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 1048-1050

  Dome, Peter ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NON PRESCRIPTION DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG SAFETY; HUMAN; NICOTINE REPLACEMENT THERAPY; SMOKING CESSATION;

HUMANS; NONPRESCRIPTION DRUGS; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS; TOBACCO USE CESSATION PRODUCTS;

EID: 80755135358     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.045     Document Type: Article

References (26)

1. Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 2009, 205:23-32.
2. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 2009, 9:655-664.
3. Hahn E.J. Smokefree legislation: a review of health and economic outcomes research. Am J Prev Med 2010, 39:S66-S76.
4. Hays J.T., Ebbert J.O. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Drugs 2010, 70:2357-2372.
5. Shiffman S., Sweeney C.T. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?. Health Policy 2008, 86:17-26.
6. Shiffman S., Brockwell S.E., Pillitteri J.L., Gitchell J.G. Use of smoking-cessation treatments in the United States. Am J Prev Med 2008, 34:102-111.
7. Shiffman S., Hughes J.R., Pillitteri J.L., Burton S.L. Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample. Tob Control 2003, 12:310-316.
8. Hughes JR, Peters EN, Naud S. Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials. Nicotine Tob Res 2011 Apr 6. [Epub ahead of print].
9. Etter J.F., Burri M., Stapleton J. The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis. Addiction 2007, 102:815-822.
10. Greene N.M., Taylor E.M., Gage S.H., Munafò M.R. Industry funding and placebo quit rate in clinical trials of nicotine replacement therapy: a commentary on Etter et al. (2007). Addiction 2010, 105:2217-2218.
11. Zapawa L.M., Hughes J.R., Benowitz N.L., Rigotti N.A., Shiffman S. Cautions and warnings on the US OTC label for nicotine replacement: what's a doctor to do?. Addict Behav 2011, 36:327-332.
12. Hajek P., McRobbie H., Gillison F. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med 2007, 44:230-234.
13. http://www.askapatient.com/viewrating.asp?drug=18612&name=NICORETTE&sort=timelength&page=1&PerPage=80.
14. Lewis S.A., Haw S.J., McNeill A. The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy. Nicotine Tob Res 2008, 10:1789-1792.
15. Besaratinia A., Pfeifer G.P. Second-hand smoke and human lung cancer. Lancet Oncol 2008, 9:657-666.
16. Dome P., Lazary J., Kalapos M.P., Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 2010, 34:295-342.
17. Egleton R.D., Brown K.C., Dasgupta P. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 2008, 29:151-158.
18. Murray R.P., Connett J.E., Zapawa L.M. Does nicotine replacement therapy cause cancer? Evidence from the lung health study. Nicotine Tob Res 2009, 11:1076-1082.
19. Tournier J.M., Birembaut P. Nicotinic acetylcholine receptors and predisposition to lung cancer. Curr Opin Oncol 2011, 23:83-87.
20. Stepanov I., Carmella S.G., Briggs A., Hertsgaard L., Lindgren B., Hatsukami D., et al. Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. Cancer Res 2009, 69:8236-8240.
21. Improgo MR, Tapper AR, Gardner PD. Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer. Biochem Pharmacol. 2011 May 27. [Epub ahead of print].
22. Lee P.N., Hamling J. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med 2009, 7:36.
23. Yaworski D., Robinson J., Sareen J., Bolton J.M. The relation between nicotine dependence and suicide attempts in the general population. Can J Psychiatry 2011, 56:161-170.
24. Flensborg-Madsen T., von Scholten M.B., Flachs E.M., Mortensen E.L., Prescott E., Tolstrup J.S. Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. J Psychiatr Res 2011, 45:143-149.
25. Clarke D.E., Eaton W.W., Petronis K.R., Ko J.Y., Chatterjee A., Anthony J.C. Increased risk of suicidal ideation in smokers and former smokers compared to never smokers: evidence from the Baltimore ECA follow-up study. Suicide Life Threat Behav 2010, 40:307-318.
26. Garelik D.A. Nicotine gum dependence treated with varenicline - a case report. Nicotine Tob Res 2010, 12:1041-1042.